Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders

 
 

HCW Biologics Inc. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-21Dec-31-20Dec-31-19
Revenues0.04.15,390.8
            Revenue growth-100.0%-99.9% 
Cost of goods sold0.00.07,365.3
Gross profit0.04.1-1,974.5
            Gross margin 100.0%-36.6%
Selling, general and administrative13.49.9 
General and administrative  1,974.5
EBIT-13.9-5.8-7,365.3
            EBIT margin -142.6%-136.6%
Pre-tax income-12.9-5.8-7,292.9
Income taxes0.00.00.0
            Tax rate0.0%0.0%0.0%
Net income-12.9-5.8-7,292.9
            Net margin -141.5%-135.3%
 
Diluted EPS($0.69)($1.22)($1.70)
Shares outstanding (diluted)18.84.74,286.5
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy